This team is dedicated to assisting life sciences businesses, from biotechnology start-ups to multinational pharmaceutical companies.
Biotechnology start-ups to multinational pharmaceutical companies.
Our advisers not only deepen their knowledge in workshops, seminars and over the course of their postgraduate studies but also conduct training sessions during these events.
We work closely with the KPMG Global Pharma Network – an international structure that has for many years provided advisory services to the biggest life sciences companies. Thanks to this cooperation, we are able to keep up with the latest international trends with respect to providing services for this sector. We are a specialized and experienced group of advisers who aim to provide clients with the highest levels of service upon which they can base their business decisions.
Future proofing the life sciences supply chain will require redefining the supply chain to become more agile, increasing capabilities to support demand-driven performance, and aligning value to unleash untapped assets and expertise.
The report explains the orientation of end-to-end processes as part of GBS that can enable a company to adopt new technologies more rapidly and benefit from them faster. The report also clearly lays out the five benefits, the 10 dimensions and five levels of maturity of GBS.